aTYR PHARMA INC Annual Return On Equity in % from 2020 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
aTYR PHARMA INC quarterly/annual Return On Equity history and growth rate from 2020 to 2023.
  • aTYR PHARMA INC Return On Equity for the quarter ending June 30, 2024 was -65.4 %, a 32% decline year-over-year.
  • aTYR PHARMA INC annual Return On Equity for 2023 was -49.8 %, a 8.45% increase from 2022.
  • aTYR PHARMA INC annual Return On Equity for 2022 was -54.4 %, a 27.7% decline from 2021.
  • aTYR PHARMA INC annual Return On Equity for 2021 was -42.6 %, a 7.15% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -49.8 +4.6 +8.45% Jan 1, 2023 Dec 31, 2023
2022 -54.4 -11.8 -27.7% Jan 1, 2022 Dec 31, 2022
2021 -42.6 +3.28 +7.15% Jan 1, 2021 Dec 31, 2021
2020 -45.9 Jan 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.